Mojdeh Poul

CIK 1743760 · View on SEC EDGAR ↗

Insider

First SEC filing: June 5, 2023 · Latest: March 20, 2025

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 82 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

82 other filings hidden
Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
May 17, 2022 MMM S 1,634 $151.68 $247,845 7,637 Direct -17.62% Disposed 41.8% (price as of 2026-08-21)
May 3, 2021 MMM S 778 $198.64 $154,542 2,315 Direct -25.15% Disposed 8.3% (price as of 2026-08-21)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
May 20, 2026 ALGN Restricted Stock Units Common Stock (1,836) — — 1,836 Acquired
May 20, 2026 ALGN Restricted Stock Units Common Stock (1,745) — — 1,745 Disposed
March 18, 2025 SWK Deferred Shares Common Stock (35) — — 35 Acquired
Jan. 6, 2025 IART Restricted Stock Units Common Stock (103,688) $0.00 — 103,688 Acquired
Jan. 6, 2025 IART Non- Qualified Stock Option (right to buy) Common Stock (217,961) $21.70 Jan. 6, 2033 217,961 Acquired
Dec. 17, 2024 SWK Deferred Shares Common Stock (34) — — 34 Acquired
Sept. 17, 2024 SWK Deferred Shares Common Stock (27) — — 27 Acquired
June 18, 2024 SWK Deferred Shares Common Stock (33) — — 33 Acquired
May 22, 2024 ALGN Restricted Stock Units Common Stock (660) — — 660 Disposed
May 22, 2024 ALGN Restricted Stock Units Common Stock (1,148) — — 1,148 Acquired
March 19, 2024 SWK Deferred Shares Common Stock (31) — — 31 Acquired
Dec. 19, 2023 SWK Deferred Shares Common Stock (28) — — 28 Acquired
Dec. 15, 2023 SWK Deferred Shares Common Stock (313) — — 313 Acquired
Dec. 5, 2023 ALGN Restricted Stock Unit Common Stock (660) — — 660 Acquired
Sept. 19, 2023 SWK Deferred Shares Common Stock (25) — — 25 Acquired
Sept. 15, 2023 SWK Deferred Shares Common Stock (357) — — 357 Acquired
June 20, 2023 SWK Deferred Shares Common Stock (20) — — 20 Acquired
June 15, 2023 SWK Deferred Shares Common Stock (346) — — 346 Acquired
March 21, 2023 SWK Deferred Shares Common Stock (19) — — 19 Acquired
March 15, 2023 SWK Deferred Shares Common Stock (395) — — 395 Acquired
Dec. 20, 2022 SWK Deferred Shares Common Stock (16) — — 16 Acquired
Dec. 15, 2022 SWK Deferred Shares Common Stock (400) — — 400 Acquired
Sept. 20, 2022 SWK Deferred Shares Common Stock (10) — — 10 Acquired
Sept. 15, 2022 SWK Deferred Shares Common Stock (360) — — 360 Acquired
June 21, 2022 SWK Deferred Shares Common Stock (6) — — 6 Acquired
June 15, 2022 SWK Deferred Shares Common Stock (293) — — 293 Acquired
May 17, 2022 MMM Non-qualified Stock Option (Right to Buy) Common Stock (1,634) $101.49 Feb. 3, 2023 1,634 Disposed
March 22, 2022 SWK Deferred Shares Common Stock (3) — — 3 Acquired
March 15, 2022 SWK Deferred Shares Common Stock (215) — — 215 Acquired
Feb. 8, 2022 MMM Restricted Stock Units Common Stock (12,087) — — 12,087 Acquired
Dec. 21, 2021 SWK Deferred Shares Common Stock (2) — — 2 Acquired
Dec. 15, 2021 SWK Deferred Shares Common Stock (164) — — 164 Acquired
Sept. 21, 2021 SWK Deferred Shares Common Stock (1) — — 1 Acquired
Sept. 15, 2021 SWK Deferred Shares Common Stock (169) — — 169 Acquired
June 22, 2021 SWK Deferred Shares Common Stock (0) — — 0 Acquired
June 15, 2021 SWK Deferred Shares Common Stock (154) — — 154 Acquired
May 3, 2021 MMM Non-qualified Stock Option (Right to Buy) Common Stock (778) $87.89 Feb. 7, 2022 778 Disposed
March 15, 2021 SWK Deferred Shares Common Stock (75) — — 75 Acquired
Feb. 2, 2021 MMM Non-qualified Stock Option (Right to Buy) Common Stock (20,543) $175.02 Feb. 1, 2031 20,543 Acquired
Feb. 2, 2021 MMM Restricted Stock Units Common Stock (2,973) — — 2,973 Acquired
Feb. 4, 2020 MMM Non-qualified Stock Option (Right to Buy) Common Stock (54,019) $157.24 Feb. 3, 2030 54,019 Acquired
Feb. 5, 2019 MMM Incentive Stock Option (Right to Buy) Common Stock (33,172) $201.12 Feb. 4, 2029 33,172 Acquired
Feb. 5, 2019 MMM Incentive Stock Option (Right to Buy) Common Stock (33,172) $201.12 Feb. 4, 2029 33,172 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 10 holdings

Securities held when first becoming an insider, per SEC Form 3.

Date Ticker Security Shares Ownership
June 5, 2023 IRTC Common Stock [F1] 0 Direct
Feb. 25, 2021 SWK Common Stock 0 Direct
July 10, 2018 MMM Common Stock 331 Direct
July 10, 2018 MMM Non-qualified Stock Option (Right to Buy)→ Common Stock (778) 778 Direct
July 10, 2018 MMM Non-qualified Stock Option (Right to Buy)→ Common Stock (1,634) 1,634 Direct
July 10, 2018 MMM Non-qualified Stock Option (Right to Buy)→ Common Stock (2,921) 2,921 Direct
July 10, 2018 MMM Non-qualified Stock Option (Right to Buy)→ Common Stock (6,194) 6,194 Direct
July 10, 2018 MMM Non-qualified Stock Option (Right to Buy)→ Common Stock (7,203) 7,203 Direct
July 10, 2018 MMM Non-qualified Stock Option (Right to Buy)→ Common Stock (6,749) 6,749 Direct
July 10, 2018 MMM Non-qualified Stock Option (Right to Buy)→ Common Stock (4,899) 4,899 Direct

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

MMM

President, Health Care
Fiscal year Salary Bonus Stock awards Option awards Non-equity incentive Pension change Other Total
2022 $413,881 — $3,926,295 — $183,107 — $102,871 $4,626,154
2021 $742,296 — — — $1,229,041 — $163,903 $4,216,571
2020 $683,246 — $1,165,400 $1,165,730 $305,529 — $107,452 $3,427,357

IART

Fiscal year Salary Bonus Stock awards Option awards Non-equity incentive Pension change Other Total
2025 $1,009,616 $350,438 — — $174,563 — $371,056 $9,375,551

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.